Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
about
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation.Reconstitution of self-tolerance after hematopoietic stem cell transplantationAccumulation of CD4+ T cells in the colon of CsA-treated mice following myeloablative conditioning and bone marrow transplantation.Age-related factors in cyclosporine-induced syngeneic graft-versus-host disease: regulatory role of marrow-derived T lymphocytes.Demonstration of large-scale migration of cortical thymocytes to peripheral lymphoid tissues in cyclosporin A-treated rats.Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparitiesCyclosporine-induced autoimmunity and immune hyperreactivity.Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.Images of self: a model for tonic peripheral tolerance.Graft-versus-leukemia effect and its clinical implications.Antitumor activity of syngeneic/autologous graft-versus-host disease.Immunobiology and immunotherapeutic implications of syngeneic/autologous graft-versus-host disease.Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, bis(tri-n-butyltin) oxide and cyclosporine on thymus histophysiology.Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.Busulfan depletes neutrophils and delays accelerated acute rejection of discordant xenografts in the guinea pig-to-rat model.Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
P2860
Q33348608-7DB75FC3-5983-464A-B155-0F5B16B316AFQ33945960-4E7E4B89-CDE6-40FB-8BC7-D3BBAFE79297Q34979948-F55978D1-3355-48E0-A57D-B4728C05568EQ36352047-48659A6C-4797-4714-9A7B-858186896C62Q36361927-9F44054E-5B59-48BE-A867-5FD2A31ACA2CQ37306402-7493C2AE-583F-4ABE-9477-5E2626FB39F1Q37526325-CA3561FF-D45C-4D2E-80E9-F8D32B0151FEQ37637433-A0D9DA48-A0FA-406D-842A-6AA3B0AC567CQ40618214-CBC93431-645F-482C-98EE-DF729C5D5533Q40920988-E006A256-6395-41F6-A061-391C42A6917AQ40967655-BA6C5902-499B-4A58-895C-8920F45B0695Q41561705-D9308A2E-C39D-40AD-ABC9-04853E8049FEQ41570922-E35A96F2-6B40-4934-8B5C-F508C890FDAFQ43480762-15371309-AFA1-469B-9B20-1AD62F28AFCCQ44289707-09B223B3-EBFC-4E2B-9356-F5E093F88809Q44603437-EE4B5D87-823E-4035-B578-C107602044A9
P2860
Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Requirements for the induction ...... eic graft-versus-host disease.
@ast
Requirements for the induction ...... eic graft-versus-host disease.
@en
type
label
Requirements for the induction ...... eic graft-versus-host disease.
@ast
Requirements for the induction ...... eic graft-versus-host disease.
@en
prefLabel
Requirements for the induction ...... eic graft-versus-host disease.
@ast
Requirements for the induction ...... eic graft-versus-host disease.
@en
P2093
P2860
P356
P1476
Requirements for the induction ...... eic graft-versus-host disease.
@en
P2093
A C Fischer
W E Beschorner
P2860
P304
P356
10.1084/JEM.169.3.1031
P407
P577
1989-03-01T00:00:00Z